Last SFr.58.80 CHF
Change Today -0.20 / -0.34%
Volume 707.8K
ATLN On Other Exchanges
Symbol
Exchange
OTC US
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
OTC US
As of 11:43 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter Wipf

Member of Scientific Advisory Board, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Prof. Peter Wipf serves as Director of the Combinatorial Chemistry Center at University of Pittsburgh. In 1990, Prof. Wipf became an Assistant Professor at the University of Pittsburgh, and was promoted to Associate Professor in 1995 and Professor in 1997. Prof. Wipf's research interests are focused on the total synthesis of natural products, heterocyclic and organometallic chemistry. He has founded, and serves as the first Director of the Combinatorial Chemistry Center ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1984
Universität Zürich
PhD 1987
Universität Zürich

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.58.80 CHF -0.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$700.0K
Jason T. Flatley Chief Executive Officer, President and Director
Illumina Inc.
$1.0M
Martine A. Rothblatt Ph.D., J.D., MBAFounder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$959.6K
Ulf Arne Wiinberg Chief Executive Officer, President and Member of the Board of Management
H. Lundbeck A/S
--
Giovanni Recordati Chairman, Chief Executive Officer and General Manager
Recordati SpA
€860.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.